PMID: 7932277Mar 1, 1994Paper

Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews?

Journal of Psychiatric Research
B Knäuper, H U Wittchen

Abstract

Recent epidemiological and family genetic studies in different countries using standardized diagnostic interviews for mental disorders have rather consistently demonstrated considerably lower current (e.g. ECA Study: 0.9%) and lifetime (1.4%) prevalence estimates of Major Depression in the elderly (older than 65 years of age) as compared to younger age groups (e.g. 30-44 years: 1 year, 3.9%; lifetime, 7.5%). Some investigators have questioned the validity of these data and suggested alternative interpretations. One possibility is that the complex standardized symptoms and clinical probe questions, and the required judgmental process inherent in diagnostic interviews exceed the cognitive capacity of older adults. This may result in systematic response bias. This paper examines the degree to which the lower prevalence estimates of depression in the elderly are biased due to specific characteristics of the assessment strategy. Analyses of epidemiologic data from the Munich Follow-up Study (MFS), based on the Diagnostic Interview Schedule, demonstrate that (1) older respondents report lifetime depressive symptoms with the same frequency as younger respondents. The additional probe questions designed to identify the degree to which ...Continue Reading

References

Oct 1, 1979·Cognitive Psychology·G Cohen
Jan 1, 1977·International Journal of Aging & Human Development·B GurlandP Birkett
Aug 1, 1975·Archives of General Psychiatry·M D Blumenthal
Mar 1, 1992·Psychology and Aging·R C KesslerJ S House
Jan 1, 1992·European Archives of Psychiatry and Clinical Neuroscience·H U WittchenM Zaudig
Jan 1, 1991·Journal of Psychiatric Research·M G WarshawP W Lavori
Aug 1, 1991·Psychological Medicine·R C Kessler, E Wethington
Mar 1, 1991·Psychology and Aging·T A SalthouseR J Shaw
Jun 1, 1989·Psychology and Aging·J P Newmann
Feb 1, 1989·Psychological Medicine·L N Robins
Jun 1, 1987·The Australian and New Zealand Journal of Psychiatry·P W Burvill
Jan 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·G L Klerman
Jan 1, 1988·Experimental Aging Research·A WingfieldJ S Aberdeen
Dec 1, 1986·Psychology and Aging·E L StineL W Poon
Sep 1, 1988·Psychology and Aging·Willard L RodgersFrank M Andrews
Jan 1, 1987·Experimental Aging Research·E A Stine, A Wingfield
May 1, 1986·The Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology·R H Logie
Nov 1, 1986·The Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology·A BaddeleyH Spinnler
Nov 1, 1985·Journal of Gerontology·L L Light, P A Anderson
Mar 1, 1972·Journal of Health and Social Behavior·C M Gaitz, J Scott
Feb 1, 1981·Cognition·G Cohen
Feb 1, 1993·Journal of Abnormal Psychology·P M LewinsohnS A Fischer

❮ Previous
Next ❯

Citations

Oct 23, 2001·Depression and Anxiety·E J LenzeC F Reynolds
Jan 1, 1997·New Directions for Mental Health Services·J L PearsonJ M Lyness
Jan 1, 1995·European Archives of Psychiatry and Clinical Neuroscience·M M FichterK Merikangas
Jan 20, 2011·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·A MehnertS Andreas
Apr 11, 2009·Social Psychiatry and Psychiatric Epidemiology·Katja BeesdoHans-Ulrich Wittchen
Dec 6, 2005·European Archives of Psychiatry and Clinical Neuroscience·Christine FröhlichHans-Ulrich Wittchen
Jun 1, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R D GoodwinH U Wittchen
Jun 18, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hans-Ulrich Wittchen, Frank Jacobi
Jul 13, 2005·Progress in Biophysics and Molecular Biology·Shant Der SarkissianMohan K Raizada
Mar 7, 1998·Journal of Behavior Therapy and Experimental Psychiatry·K Fuentes, B J Cox
Aug 17, 2002·Biological Psychiatry·George S AlexopoulosDavid W Oslin
Apr 5, 2002·Trends in Pharmacological Sciences·Anthony J Turner, Nigel M Hooper
Mar 1, 1996·Psychological Medicine·G L KlermanH Akiskal
Jul 1, 2011·Journal of the International Neuropsychological Society : JINS·Bruce R ReedDan Mungas
Mar 19, 2003·Psychology and Aging·Klaus Rothermund, Jochen Brandtstädter
Jul 21, 2005·Psychology and Aging·Alan TuohyMichael J Wrennall
Oct 27, 2005·Psychology and Aging·Gail J McAvayMartha L Bruce
Jun 17, 2006·Aging & Mental Health·G A Brenes
Jun 9, 2012·The International Journal of Behavioral Nutrition and Physical Activity·Johannes MichalakFrank Jacobi
Jun 29, 2006·Home Health Care Services Quarterly·Kathleen Ell
May 1, 2001·Suicide & Life-threatening Behavior·Y Conwell
Dec 17, 2009·The Australian and New Zealand Journal of Psychiatry·Veronica Kimber, Saxby Pridmore
Jun 1, 2013·Psychological Medicine·R D McDowellT Tomov
Nov 17, 2005·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Jürgen BrunnerHans-Ulrich Wittchen
Oct 18, 2012·Journal of Psychiatric Research·Renee D GoodwinFrank Jacobi
Mar 13, 2009·Journal of Anxiety Disorders·Katja BeesdoHans-Ulrich Wittchen
Jan 13, 2009·General Hospital Psychiatry·Gregory E RatcliffeJitender Sareen
Jun 5, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Julian N TrollorGavin Andrews
Feb 3, 2007·Journal of Psychosomatic Research·Kari A LeiknesInger Sandanger
Aug 13, 2015·International Psychogeriatrics·Olusegun BaiyewuAdefolakemi Ogundele
Nov 28, 2012·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R D GoodwinF Jacobi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.